Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Buy Antofagasta (ANTO) by Bank of America
- Outperform Relx plc (REL) by ODDO BHF
- Outperform Chesnara (CSN) by RBC Capital
- Buy Yellow Cake (YCA) by Berenberg
- Outperform NextEnergy Solar Fund Limited Red (NESF) by RBC Capital
- Buy Applied Nutrition (APN) by Deutsche Bank
- Neutral Legal & General Group (LGEN) by Exane
- Hold Unilever (ULVR) by Kepler Cheuvreux
- Hold Unilever (ULVR) by Berenberg
- Neutral NATWEST GROUP (NWG) by Goldman Sachs
- Buy Antofagasta (ANTO) by Goldman Sachs
- Overweight Molten Ventures (GROW) by Barclays
- Buy Melrose Industries (MRO) by Citi
- Buy AstraZeneca (AZN) by Berenberg
- Neutral Inchcape (INCH) by JP Morgan
- Underweight Admiral Group (ADM) by JP Morgan
- Buy Barr (A.G.) (BAG) by John Ficenec in The Times - Tempus
- Avoid Physiomics (PYC) by Steve Moore in ShareProphets
- Avoid Pinewood Technologies Group (PINE) by Steve Moore in ShareProphets
- Underweight HGCapital Trust (HGT) by JP Morgan
Avacta Group (AVCT) Share Price
Health Care Sector
NOTE: This is based on 63 open tips for Avacta Group (AVCT)
| Latest Bid : 53.00p | Latest Ask : 55.00p |
| High Today : 57.00p | Low Today : 53.00p |
| This Years High : 82.50p | This Years Low : 27.50p |
| Volume : 365,398 | MKT Cap : £202.95M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000
Avacta Group (AVCT) Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.Avacta Group (AVCT) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 50.67% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 36.83% |
| Sell | Tom Winnifrith | Premium Only | 2022-10-18 14:10:00 18/10/2022 | 28.87% |
| Sell | Cat Jeeves | Premium Only | 2022-10-01 17:20:00 01/10/2022 | 42.25% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-27 17:15:00 27/09/2022 | 47.39% |
Avacta Group (AVCT) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 53.00p | Latest Ask : 55.00p |
| High Today : 57.00p | Low Today : 53.00p |
| This Years High : 82.50p | This Years Low : 27.50p |
| Volume : 365,398 | MKT Cap : £202.95M |
Avacta Group Overview
Avacta is a clinical stage oncology drug company and developer of powerful diagnostics based on its innovative, proprietary Affimer® and pre|CISION platforms.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Avacta Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Lucian Miers | Premium Only | 2023-12-24 13:45:00 24/12/2023 | 50.67% |
| Avoid | Kevin Godbold | Premium Only | 2022-10-24 15:35:00 24/10/2022 | 36.83% |
| Sell | Tom Winnifrith | Premium Only | 2022-10-18 14:10:00 18/10/2022 | 28.87% |
| Sell | Cat Jeeves | Premium Only | 2022-10-01 17:20:00 01/10/2022 | 42.25% |
| Sell | Tom Winnifrith | Premium Only | 2022-09-27 17:15:00 27/09/2022 | 47.39% |
Stock Splits and Consolidations
26/01/2016 – Stock Consolidation 100.000:1.000